Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

Nilotinib is an FDA approved drug used for the treatment of Philadelphia Chromosome Positive CML, which is a cancer of blood ...

Mumbai: Cipla, an Indian multinational pharmaceutical company, has announced that the United States Food and Drugs ...

Cipla announced that it has received final approval from the United States Food and Drug Administration (USFDA) for the new drug application (NDA) submitted for 'Nilotinib Capsules 50, 150 and 200 mg' ...

HYDERABAD, India (Reuters) - Indian pharmaceutical companies will be able to retain their dominant market share in the U.S.

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, ...

The U.S. foreign aid freeze has severely impacted the supply chain for medical products in poor countries, causing potential shortages in HIV and malaria treatments. This disruption affects major ...

The freeze has put orders and forecasts, particularly those made months in advance, on hold. Read more at straitstimes.com.

Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

Government data shows that the US is the biggest market for Indian drugmakers. The country, which boasts of being the ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...